Chronic flavanol-rich cocoa powder supplementation reduces body fat mass in endurance athletes by modifying the follistatin/myostatin ratio and leptin levels.


Journal

Food & function
ISSN: 2042-650X
Titre abrégé: Food Funct
Pays: England
ID NLM: 101549033

Informations de publication

Date de publication:
30 Apr 2020
Historique:
pubmed: 3 4 2020
medline: 25 2 2021
entrez: 3 4 2020
Statut: ppublish

Résumé

Flavanols-rich cocoa has positive effects on lipid metabolism and might enhance the performance of athletes through an improvement in their body composition. To test this hypothesis a placebo-controlled intervention study in training endurance athletes who received 5 g of cocoa daily (425 mg of flavanols) for 10 weeks was performed. Dietary intake, body composition, exercise performance and plasma levels of follistatin, myostatin and leptin were measured. Cocoa intake significantly reduced body fat percentage (p = 0.020), specifically in the trunk (p = 0.022), visceral area (p = 0.034) and lower limbs (p = 0.004). The reduction in body fat mass was accompanied by an increase in plasma follistatin and a decrease in leptin, while myostatin levels remained unchanged. The intake of cocoa reduced the percentage of body fat of athletes, without any impact on athletes' performance. The change in fat body composition did not improve athletes' performance.

Identifiants

pubmed: 32236212
doi: 10.1039/d0fo00246a
doi:

Substances chimiques

Flavonols 0
Follistatin 0
Leptin 0
Myostatin 0

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

3441-3450

Auteurs

Jose Ángel García-Merino (J)

MAS microbiota group, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Spain. mar.larrosa@universidadeuropea.es.

Diego Moreno-Pérez (D)

Departamento de Educación, Métodos de Investigación y Evaluación, Universidad Pontificia de Comillas, ICAI-ICADE, Cantoblanco, Madrid 28015, Spain.

Beatriz de Lucas (B)

MAS microbiota group, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Spain. mar.larrosa@universidadeuropea.es.

Maria Gregoria Montalvo-Lominchar (MG)

MAS microbiota group, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Spain. mar.larrosa@universidadeuropea.es.

Elsa Muñoz (E)

Medical Service, Universidad Europea de Madrid, Spain.

Lara Sánchez (L)

Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Spain.

Fernando Naclerio (F)

Department of Life and Sports Sciences, University of Greenwich, Eltham SE9 2TB, UK.

Karen Marlene Herrera-Rocha (KM)

Grupo de Investigación en Alimentos Funcionales y Nutracéuticos. Unidad de Posgrado, Investigación y Desarrollo Tecnológico. TecNM/Instituto Tecnológico de Durango, Durango, Mexico.

Martha Rocío Moreno-Jiménez (MR)

Grupo de Investigación en Alimentos Funcionales y Nutracéuticos. Unidad de Posgrado, Investigación y Desarrollo Tecnológico. TecNM/Instituto Tecnológico de Durango, Durango, Mexico.

Nuria Elisabeth Rocha-Guzmán (NE)

Grupo de Investigación en Alimentos Funcionales y Nutracéuticos. Unidad de Posgrado, Investigación y Desarrollo Tecnológico. TecNM/Instituto Tecnológico de Durango, Durango, Mexico.

Mar Larrosa (M)

MAS microbiota group, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Spain. mar.larrosa@universidadeuropea.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH